GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy in patients with previously irradiated intracranial neoplasms (brain tumors) at the American Brachytherapy Society (ABS) 2019 Annual Meeting, June 13-15 in Miami. These data reinforce the safety profile of GammaTile Therapy, a surgically targeted radiation therapy (STaRT) that is designed to delay tumor regrowth for patients with recurrent intracranial neoplasms (brain tumors).

A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their prostate cancer. The findings come at a time when a growing number of men with prostate cancer considered “low risk” are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation.

An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for imaging techniques to help diagnose multiple myeloma and other plasma-cell disorders.

Sectra has signed a five-year contract with North Tees and Hartlepool National Health System (NHS) Foundation Trust for the delivery of a regional digital pathology solution to the Northern Cancer Alliance in the U.K. The solution will span the 10 separate trusts of the consortium, and aims to improve cancer care workflows through enabling pathologists to instantly access and share images and information between departments and locations.

IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and clinically implemented a novel automated treatment log-based patient quality assurance (QA) approach for proton therapy. This enables them to reduce the time needed for the in-beam measurement-based conventional patient QA.

M*Modal announced that the company and Community Health Network (CHNw) are collaborating to transform the patient-physician experience while improving provider and clinician satisfaction and care quality.

iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to iCAD’s deep-learning, artificial intelligence (AI) platform and follows the launch of ProFound AI for Digital Breast Tomosynthesis (DBT), which was CE Marked in March 2018 and U.S. Food and Drug Administration (FDA)-cleared in December 2018. ProFound AI for 2D Mammography and ProFound AI for DBT will both be featured in the iCAD exhibition booth at the Société Française d'Imagerie de la FEMme (SIFEM) medical conference June 13-15, 2019, in Lille, France.

Utah Valley Hospital (Provo, Utah) has installed nine Carestream imaging systems that equip its radiology staff to deliver rapid, high-quality imaging throughout the 395-bed facility. The imaging systems include two Carestream DRX-Evolution Plus digital radiography (DR) systems, six Carestream DRX-Revolution mobile X-ray systems and one Carestream DRX-Retrofit Kit to upgrade an existing portable system to DR technology. The hospital is a member of Intermountain Healthcare.

Core Sound Imaging announced the addition of two-factor authentication (2FA) to the security measures available for the Studycast system, the company's cloud-based picture archiving and communication system (PACS) and reporting solution. For clients who choose to use 2FA, this addition will enhance system security by requiring users to enter a time-sensitive access code in addition to their username and password.